Flaxseed oil and inflammation-associated bone abnormalities in interleukin-10 knockout mice

Journal of Nutritional Biochemistry

Volumn 16, Issue 6, 2005, Pages 368-374

  Cohen, Stacey L ^a   Moore, Aideen M ^b   Ward, Wendy E ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Bone mass; Flaxseed oil; Inflammatory bowel disease; Interleukin 10 knockout mice

Indexed keywords

INTERLEUKIN 10; LINOLENIC ACID; LINSEED OIL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; AUTOPSY; BONE DEFECT; BONE DENSITY; DIETARY INTAKE; DISEASE ASSOCIATION; ENTERITIS; FEEDING; FEMALE; FEMUR; KNOCKOUT MOUSE; LUMBAR VERTEBRA; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PERINATAL PERIOD; WEANING; WILD TYPE;

ANIMALS; BIOMECHANICS; BONE DENSITY; BONE DISEASES; DIETARY FATS, UNSATURATED; DISEASE MODELS, ANIMAL; FATTY ACIDS; FEMUR; INFLAMMATORY BOWEL DISEASES; INTERLEUKIN-10; LINSEED OIL; LUMBAR VERTEBRAE; MALE; MICE; MICE, KNOCKOUT;

ZEA MAYS;

EID: 20144371603     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2005.01.008     Document Type: Article

References (50)

1. S.L. Cohen, A.M. Moore, and W.E. Ward Interleukin-10 knockout mouse: a model for studying bone metabolism during intestinal inflammation Inflamm. Bowel Dis. 10 2004 557 563
2. H.R. Jenkins Inflammatory bowel disease Arch. Dis. Child. 85 2001 435 437
3. D. Sun, A. Krishnan, K. Zaman, R. Lawrence, A. Bhattacharya, and G. Fernandes Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized mice J. Bone Miner. Res. 18 2003 1206 1216
4. V. Abitbol, C. Roux, and S. Chaussade Metabolic bone assessment in patients with inflammatory bowel disease Gastroenterology 108 1995 417 422
5. R.D. Pollak, F. Karmeli, R. Eliakim, Z. Ackerman, K. Tabb, and D. Rachmilewitz Femoral neck osteopenia in patients with inflammatory bowel disease Am. J. Gastroenterol. 93 1998 1483 1490
6. C. Roux, V. Abitbol, and S. Chaussade Bone loss in patients with inflammatory bowel disease: a prospective study Osteoporos. Int. 5 1995 156 160
7. J. Klaus, G. Armbrecht, and M. Steinkamp High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease Gut 51 2002 654 658
8. A. Habtezion, M.S. Silverberg, R. Parkes, S. Mikolainis, and A.H. Steinhart Risk factors for low bone density in Crohn's disease Inflamm. Bowel Dis. 8 2002 87 92
9. I. Bjarnason, A. Macpherson, C. Mackintosh, M. Buxton-Thomas, I. Forgacs, and C. Moniz Reduced bone density in patients with inflammatory bowel disease Gut 40 1997 228 233
10. M. Thearle, M. Horlick, and J.P. Bilezikian Osteoporosis: An unusual presentation of childhood Crohn's disease J. Clin. Endocrinol. Metab. 85 2000 2122 2126
11. A.M. Boot, J. Bouquet, E.P. Krenning, and S.M. de Muinck Keizer-Schrama Bone mineral density and nutritional status in children with chronic inflammatory bowel disease Gut 42 1998 188 194
12. F.J. Cowan, J.T. Warner, F.D. Dunstan, W.D. Evans, J.W. Gregory, and H.R. Jenkins Inflammatory bowel disease and predisposition to osteopenia Arch. Dis. Child. 76 1997 325 329
13. M. Dinca, W. Fries, and G. Luisetto Evolution of osteopenia in inflammatory bowel disease Am. J. Gastroenterol. 94 1999 1292 1297
14. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases Gastroenterology 124 2003 791 794
15. C.N. Bernstein, W.D. Leslie, and S.P. Taback Bone density in a population-based cohort of premenopausal adult women with early onset inflammatory bowel disease Am. J. Gastroenterol. 98 2003 1094 1100
16. R.P. Heaney, S. Abrams, and B. Dawson-Hughes Peak bone mass Osteoporos. Int. 11 2000 985 1009
17. J. Nishimura, and S. Ikuyama Glucocorticoid-induced osteoporosis: pathogenesis and management J. Bone Miner. Metab. 18 2000 350 352
18. N. Nieto, M.I. Torres, A. Rios, and A. Gil Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis J. Nutr. 132 2002 11 19
19. W.F. Stenson, D. Cort, and J. Rodgers Dietary supplementation with fish oil in ulcerative colitis Ann. Intern. Med. 116 1992 609 614
20. A. Aslan, and G. Triadafilopoulos Fish oil fatty acid supplementation in active ulcerative colitis: a double-blind, placebo-controlled, crossover study Am. J. Gastroenterol. 87 1992 432 437
21. Y. Li, R.S. Greiner, N. Salem Jr., and B.A. Watkins Impact of dietary n-3 fatty acid deficiency on rat bone tissue fatty acid composition Lipids 38 2003 683 686
22. S. Reinwald, Y. Li, T. Moriguchi, N. Salem Jr., and B.A. Watkins Repletion with (n-3) fatty acids reverses bone structural deficits in (n-3)-deficient rats J. Nutr. 134 2004 388 394
23. G.E. Caughey, E. Mantzioris, R.A. Gibson, L.G. Cleland, and M.J. James The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil Am. J. Clin. Nutr. 63 1996 116 122
24. S.C. Cunnane, M.J. Hamadeh, A.C. Liede, L.U. Thompson, T.M. Wolever, and D.J. Jenkins Nutritional attributes of traditional flaxseed in healthy young adults Am. J. Clin. Nutr. 61 1995 62 68
25. D.S. Kelley Immunomodulatory effects of flaxseed and other oils rich in alpha-linolenic acid L.U. Thompson S.C. Cunnane Flaxseed in Human Nutrition 1st ed. 1995 AOCS Champaign (Ill) 152
26. B.C. Davis, and P.M. Kris-Etherton Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications Am. J. Clin. Nutr. 78 2003 640S 646S
27. F.A. Wallace, E.A. Miles, and P.C. Calder Comparison of the effects of linseed oil and different doses of fish oil on mononuclear cell function in healthy human subjects Br. J. Nutr. 89 2003 679 689
28. U.N. Das, E.J. Ramos, and M.M. Meguid Metabolic alterations during inflammation and its modulation by central actions of omega-3 fatty acids Curr. Opin. Clin. Nutr. Metab. Care 6 2003 413 419
29. A. Belluzzi, S. Boschi, C. Brignola, A. Munarini, G. Cariani, and F. Miglio Polyunsaturated fatty acids and inflammatory bowel disease Am. J. Clin. Nutr. 71 2000 339S 342S
30. J.E. Teitelbaum, and W. Allan Walker Review: the role of omega 3 fatty acids in intestinal inflammation J. Nutr. Biochem. 12 2001 21 32
31. B.A. Watkins, Y. Li, K.G. Allen, W.E. Hoffmann, and M.F. Seifert Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats J. Nutr. 130 2000 2274 2284
32. B.A. Watkins, Y. Li, and M.F. Seifert Nutraceutical fatty acids as biochemical and molecular modulators of skeletal biology J. Am. Coll. Nutr. 20 2001 410S 416S [discussion 417S-420S]
33. B.A. Watkins, Y. Li, H.E. Lippman, and S. Feng Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism Prostaglandins Leukot. Essent. Fatty Acids 68 2003 387 398
34. D. Wu, S.N. Meydani, M. Meydani, M.G. Hayek, P. Huth, and R.J. Nicolosi Immunologic effects of marine- and plant-derived n-3 polyunsaturated fatty acids in nonhuman primates Am. J. Clin. Nutr. 63 1996 273 280
35. H. Weiler, H. Kovacs, E. Nitschmann, S. Fitzpatrick Wong, N. Bankovic-Calic, and M. Ogborn Elevated bone turnover in rat polycystic kidney disease is not due to prostaglandin E2 Pediatr. Nephrol. 17 2002 795 799
36. M.J. James, S.M. Proudman, and L.G. Cleland Dietary n-3 fats as adjunctive therapy in a prototypic inflammatory disease: issues and obstacles for use in rheumatoid arthritis Prostaglandins Leukot. Essent. Fatty Acids 68 2003 399 405
37. T. Hibi, H. Ogata, and A. Sakuraba Animal models of inflammatory bowel disease J. Gastroenterol. 37 2002 409 417
38. K.L. Madsen Inflammatory bowel disease: lessons from the IL-10 gene-deficient mouse Clin. Invest. Med. 24 2001 250 257
39. K.L. Madsen, J.S. Doyle, M.M. Tavernini, L.D. Jewell, R.P. Rennie, and R.N. Fedorak Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice Gastroenterology 118 2000 1094 1105
40. Canadian Council on Animal Care Guide to the care and use of experimental animals 1984 Institute of Laboratory Animal Resources Commission on Life Sciences Ottawa
41. J. Folch, M. Lees, and G.H. Sloane Stanley A simple method for the isolation and purification of total lipides from animal tissues J. Biol. Chem. 226 1957 497 509
42. A. Bourreille, M. Doubremelle, and D.R. de la Bletiere RDP58, a novel immunomodulatory peptide with anti-inflammatory effects. A pharmacological study in trinitrobenzene sulphonic acid colitis and Crohn disease Scand. J. Gastroenterol. 38 2003 526 532
43. R. Boismenu, and Y. Chen Insights from mouse models of colitis J. Leukoc. Biol. 67 2000 267 278
44. D.M. Rennick, and M.M. Fort Lessons from genetically engineered animal models: XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation Am. J. Physiol. Gastrointest. Liver Physiol. 278 2000 G829 G833
45. D. Fonseca, and W.E. Ward Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice Bone 35 2004 489 497
46. R. Dresner-Pollak, N. Gelb, D. Rachmilewitz, F. Karmeli, and M. Weinreb Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones Gastroenterology 127 2004 792 801
47. L.M. Salamone, T. Whiteside, D. Friberg, R.S. Epstein, L.H. Kuller, and J.A. Cauley Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women Calcif. Tissue Int. 63 1998 466 470
48. R.K. Sellon, S. Tonkonogy, and M. Schultz Resident enteric bacteria are necessary for the development of spontaneous colitis and immune system activitation in IL-10 deficient mice Infect. Immun. 66 1998 5524 5531
49. B.A. Watkins, H.E. Lippman, L. Le Bouteiller, Y. Li, and M.F. Seifert Bioactive fatty acids: role in bone biology and bone cell function Prog. Lipid Res. 40 2001 125 148
50. J.A. Conquer, and B.J. Holub Dietary docosahexaenoic acid as a source of eicosapentaenoic acid in vegetarians and omnivores Lipids 32 1997 341 345